Biotech

All Articles

FibroGen lays off 75% of US team as asset fails 2 additional trials

.FibroGen is actually drastically restructuring its service, giving up 75% of its own USA workers an...

Tracon unwind weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually determined to wind down operations weeks after an injectable im...

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on fallen short epilepsy medicine, boasts FDA manage

.Our team actually recognize that Takeda is actually wishing to locate a road to the FDA for epileps...

VBI Vaccinations apply for bankruptcy, finds possession purchase

.Immunology biotech VBI Vaccines is actually diverting dangerously near to the defining moment, with...

Celldex anti-cKIT antibody minimize hives in yet another phase 2 research

.It's hard to muscle mass in on an area as very competitive as immunology, however Celldex Therapeut...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Rehabs and also a preclinical ...

Ventyx's last hope for inflamed med sides in Crohn's failing

.Ventyx Biosciences' Crohn's ailment medication did not aid clients achieve remission in a stage 2 t...

Cognition's period 2 SHINE data stain Alzheimer's prospect

.Cognition Therapeutics' phase 2 sparkle trial has taken several of the luster off the Alzheimer's i...

BMS axes bispecific months after filing to operate stage 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its BCMA bispecific T-cel...